z-logo
open-access-imgOpen Access
GENETIC POLYMORPHISM OF TUBERCULOSIS MYCOBACTERIA IN THE CITY WITH LIMITED POPULATION MIGRATION AND HIGH INCIDENCE OF HIV INFECTION
Author(s) -
Tatiana Umpeleva,
Kseniya Belousova,
Lyudmila A. Golubeva,
Irina А. Morozova,
Natalya Eremeeva,
Diana Vakhrusheva
Publication year - 2019
Publication title -
tuberkulez i bolezni lëgkih/tuberkulëz i bolezni lëgkih
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.226
H-Index - 12
eISSN - 2542-1506
pISSN - 2075-1230
DOI - 10.21292/2075-1230-2019-97-3-40-45
Subject(s) - genotyping , tuberculosis , mycobacterium tuberculosis , genotype , typing , virology , biology , beijing , epidemiology , population , drug resistance , locus (genetics) , medicine , immunology , genetics , gene , pathology , environmental health , law , political science , china
87 isolates of M. tuberculosis isolated from tuberculosis patients in the Novouralsk municipality in 2013-2016 were studied. It was found out that a high percentage of isolates had multiple drug resistance: 66 and 85.3% among newly diagnosed and previously treated patients, respectively. Genotyping allowed revealing the dominance of isolates of the Beijing family, both among newly diagnosed (75.5%) and previously treated patients (85.3%), with 52.8 and 67.6% of isolates, respectively, belonging to the Beijing B0/W148 variant. MIRU-VNTR-typing detected nine isolates of the Beijing B0/W148 family with an atypical number of repeats in the QUB26 locus (two). A high rate of tuberculosis with concurrent HIV (39.1%) was noted, while in groups of tuberculosis patients with various HIV statuses, no difference was detected in the ratio of multiple drug resistant pathogens and belonging to the Beijing genotype (BeijingB0/W148). The article demonstrates the possibility of using genotyping technologies to confirm/deny the epidemiological relationship between patients and search for previously unknown mechanisms of tuberculosis infection transmission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here